Biotech pharma

General Proximity

Website

Overview

The next generation of induced-proximity medicines.

Company description As recorded 2026-11-08

Product & workflow

Our unbiased effector discovery platform allows us to discover the most powerful proximity mechanisms for a given target, enabling the development of highly-efficacious proximity therapeutics for targets previously beyond the reach of medicine.

Source-reported As recorded 2026-09-23

Founders & team

Previously Weatherwax Bio

Company history As recorded 2026-11-08

Armand Cognetta

Founder

Armand completed his PhD in Chemical Biology at the Scripps Research Institute under the supervision of Dr. Benjamin F. Cravatt. There he co-authored 19 scientific publications in prestigious journals such as Cell, Nature, and Science, as well as multiple patents, including a portion of the foundational IP for Abide Therapeutics (acq. Lundbeck) and Vividion Therapeutics (acq. Bayer). Prior to founding GP he was an early employee at the Flagship Pioneering start-up Inzen Tx (now Sonata).

Founder profile As recorded 2026-09-15
15team members reported
Source-reported As recorded 2026-09-15

News & product activity

Sources & observations

Y Combinator

Profile depthverified profile
Website observationwebsite reachable
Last website check2026-11-11
Location · source statedSan Francisco, CA, USA
Pricing evidenceNo pricing page confirmed
Maturity: Not assessed · 3 of 6 areas documented

Source-based assessment · automated evidence rules

The retained text does not establish product availability or customer use.

Maturity is an evidence-based assessment, not a success rating. It may understate the current stage where evidence is limited. Coverage records documented areas, not a complete or independently audited company history.

Stage definitions
independent websitesource corroborationreachable websitedescriptive evidenceclassified market and modelsourced people